Clinical Trials Sponsored by Moe Medical Devices

Total 1218 results

Abbott Medical Devices

Completed

MPP Programming Study

Heart Failure

Italy
Abbott Medical Devices

Completed

MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics

Heart Failure

Austria, France, Italy
Abbott Medical Devices

Completed

St. Jude Medical Percutaneous Mitral Valve Repair Study (SJM PMVr)

Mitral Valve Prolapse

United Kingdom
Abbott Medical Devices

Completed

RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population (RATE)

Atrial Fibrillation

United States
Abbott Medical Devices

Completed

Peripheral Nerve Stimulation Registry for Intractable Migraine Headache (Relief)

Intractable Chronic Migraine

Luxembourg, Belgium, Germany, Spain, Sweden, United Kingdom
Abbott Medical Devices

Completed

Atrial Fibrillation Management in Congestive Heart Failure With Ablation (AMICA)

Heart Failure | Persistent Atrial Fibrillation | ICD

Germany, Hungary, Spain
Abbott Medical Devices

Withdrawn

AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational (ACP LA)

Stroke | Atrial Fibrillation | Left Atrial Appendage
Abbott Medical Devices

Completed

ENHANCE-Efficacy of the Presence of Right Ventricular Apical Pacing Induced Ventricular Dyssynchrony as a Guiding Parameter for Biventricular Pacing in Patients With Bradycardia and Normal Ejection Fraction (ENHANCE)

Bradycardia

Thailand, China, Australia, India, Italy
Abbott Medical Devices

Completed

QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the QuartetTM LV Quadripolar Lead (QUARTO-II)

Heart Failure

Spain
Abbott Medical Devices

Completed

Spinal Cord Stimulation For Heart Failure (SCS HEART)

Systolic Heart Failure

Australia, Hong Kong, Japan
Abbott Medical Devices

Withdrawn

Assessment of the St. Jude Medical PorticoTM Re-sheathable Aortic Valve System - Alternative Access (PorticoALTEU)

Symptomatic Aortic Stenosis
Abbott Medical Devices

Completed

SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

Heart Failure | Sudden Cardiac Death | Tachyarrhythmias

United States
Abbott Medical Devices

Completed

Multicenter International Trial Ring AnnulopLasty (MITRAL)

Mitral Valve Insufficiency

Germany
Abbott Medical Devices

Completed

TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study (TRI-V)

Heart Failure

Germany
Abbott Medical Devices

Completed

International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension (EnligHTN III)

Hypertension | Renal Denervation

New Zealand, Australia
Abbott Medical Devices

Completed

Aortic Valve Replacement With Trifecta(TM)

Aortic Valve Stenosis | Aortic Valve Insufficiency | Regurgitation, Aortic Valve | Aortic Valve Incompetence

Canada
Abbott Medical Devices

Completed

Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER

Membranous Ventricular Septal Defects

United States
Abbott Medical Devices

Completed

OptiSense™ Performance in Detecting Atrial Episodes (SENSE-AF)

Atrial Fibrillation | Tachyarrhythmias

United States
Abbott Medical Devices

Terminated

AVJ Ablation Followed by Resynchronization Therapy in Patients With CHF and AF (AVERT-AF)

Atrial Fibrillation | Congestive Heart Failure

United States
Abbott Medical Devices

Terminated

Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain (GASPA)

Post Surgical Groin Pain

Netherlands
Abbott Medical Devices

Completed

Dependence of LV Hemodynamics on Pacing Site

Heart Failure

France
Abbott Medical Devices

Completed

Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients

Heart Failure | Ventricular Dyssynchrony

France
Abbott Medical Devices

No longer available

Emergency/Compassionate Use - AMPLATZER Duct Occluder

Patent | Ductus | Arteriosus
Abbott Medical Devices

Completed

ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System

Atherosclerosis | Peripheral Vascular Disease | Claudication

Austria, France, Germany, Belgium
Abbott Medical Devices

Completed

B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure Patients

Heart Diseases | Heart Failure | Ventricular Dysfunction

France
Abbott Medical Devices

Completed

RethinQ Study - Evaluating Pacing in Heart Failure Patients (RethinQ)

Heart Failure

United States
Abbott Medical Devices

Completed

Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configuration (PROMISE)

Sudden Cardiac Death

United States
Abbott Medical Devices

Completed

Cardiac Resynchronization Therapy Defibrillator Based Impedance Monitoring Study

Heart Failure

United States
Abbott Medical Devices

Completed

Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia

Fibromyalgia

Belgium
Abbott Medical Devices

Completed

SUNBURST (Success Using Neuromodulation With BURST) Study (SUNBURST)

Chronic Pain

United States
Abbott Medical Devices

Completed

Study of New Implantable Loop Recorder

Syncope | Tachyarrhythmias

United States
Abbott Medical Devices

Completed

Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study (Star AF II)

Atrial Fibrillation

Canada, Australia
Abbott Medical Devices

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels (ABSORB UK)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United Kingdom
Abbott Medical Devices

Terminated

A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device (VELOCITY)

Mitral Regurgitation

United States
Abbott Medical Devices

Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angina

Japan
Abbott Medical Devices

Withdrawn

ABSORB Post-Approval Clinical Study

Ischemic Heart Disease

United States
Abbott Medical Devices

Terminated

Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I) (ACT I)

Stroke | Atherosclerosis | Carotid Stenosis | Carotid Artery Disease

United States
Abbott Medical Devices

Unknown

Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back Pain

Discogenic Low Back Pain

Netherlands
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Abbott Medical Devices

Completed

A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population (SV JAPAN)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Vascular Disease | Coronary Artery Stenosis

Japan
Abbott Medical Devices

Withdrawn

Frontier Registry II Bifurcation Stent System Registry

Coronary Artery Disease
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

France, Italy, Norway, China, Spain, Germany, United Kingdom, Switzerland, Israel, Denmark, Belgium, Austria, Poland, Australia, Portugal, Argentina, Brazil, Hungary, Latvia, Netherlands, India, Greece, Malaysia, Russian Federation, South... and more
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) (PROTECT)

Carotid Artery Disease

United States
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Abbott Medical Devices

Completed

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Myocardial Ischemia | Coronary Artery Disease | Vascular Disease | Coronary Artery Stenosis | Everolimus

Netherlands, Germany, Denmark
Abbott Medical Devices

Completed

XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery (EXCEED)

Coronary Artery Disease | Atherosclerosis

United States

Clinical Trials Sponsored by Moe Medical Devices

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations